Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study
2020; Radiological Society of North America; Volume: 297; Issue: 2 Linguagem: Inglês
10.1148/radiol.2020201933
ISSN1527-1315
AutoresAbdelkader Mahammedi, Luca Saba, Achala Vagal, Michela Leali, Andrea Rossi, Mary Gaskill, Soma Sengupta, Bin Zhang, Alessandro Carriero, Suha Bachir, Paola Crivelli, Alessio Paschè, Enrico Premi, Alessandro Padovani, Roberto Gasparotti,
Tópico(s)Kawasaki Disease and Coronary Complications
ResumoHomeRadiologyVol. 297, No. 2 PreviousNext Original ResearchFree AccessResearch LetterImaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational StudyAbdelkader Mahammedi* , Luca Saba, Achala Vagal, Michela Leali, Andrea Rossi, Mary Gaskill, Soma Sengupta, Bin Zhang, Alessandro Carriero, Suha Bachir, Paola Crivelli, Alessio Paschè, Enrico Premi, Alessandro Padovani, Roberto Gasparotti*Abdelkader Mahammedi* , Luca Saba, Achala Vagal, Michela Leali, Andrea Rossi, Mary Gaskill, Soma Sengupta, Bin Zhang, Alessandro Carriero, Suha Bachir, Paola Crivelli, Alessio Paschè, Enrico Premi, Alessandro Padovani, Roberto Gasparotti*Author AffiliationsFrom the Departments of Neuroradiology (A.M., A.V., M.G.) and Neurology (S.S.), University of Cincinnati Medical Center, 234 Goodman St, Cincinnati, OH 45267; Department of Neuroradiology, Azienda Ospedaliero Universitaria di Cagliari, Monserrato (Cagliari), Italy (L.S.); Departments of Neuroradiology (R.G., M.L.) and Neurology (A. Padovani, E.P.), Spedali Civili, University of Brescia, Brescia, Italy; Department of Pediatric Neuroradiology, G. Gaslini Children's Research Hospital Genoa, Italy (A.R.); Department of Epidemiology and Biostatistics (B.Z.) and Department of Pediatrics (S.B.), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Neuroradiology, A.O.U. "Maggiore d.c." University of Eastern Piedmont, Novara, Italy (A.C., A. Paschè); and Department of Neuroradiology, Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy (P.C.).Address correspondence to A.M. (e-mail: [email protected]).Abdelkader Mahammedi* Luca SabaAchala VagalMichela LealiAndrea RossiMary GaskillSoma SenguptaBin ZhangAlessandro CarrieroSuha BachirPaola CrivelliAlessio PaschèEnrico PremiAlessandro PadovaniRoberto Gasparotti*Published Online:May 21 2020https://doi.org/10.1148/radiol.2020201933MoreSectionsPDF ToolsAdd to favoritesCiteTrack Citations ShareShare onFacebookXLinked In * A.M. and R.G. contributed equally to this work.AbstractIntroductionAn outbreak of coronavirus disease 2019 (COVID-19) began in Wuhan, China, in December 2019 and has rapidly spread around the world to become a pandemic (1). Italy was the second epicenter of the spread of the disease, and at the time of writing has a total of 222 104 cases and 31 106 deaths (1). Several studies have described the spectrum of chest imaging features of COVID-19 (2). However, to date, only a few case reports have described COVID-19–associated neurologic imaging findings (3–8). The purpose of our study was to systematically characterize neurologic symptoms and neuroimaging features in hospitalized patients with COVID-19 from multiple institutions in Italy.Materials and MethodsStudy Design and Patient PopulationWe used a retrospective, multicenter study design from three major institutions in Italy (University of Brescia, Brescia; University of Eastern Piemonte, Novara; and University of Sassari, Sassari). Institutional review board approval and waivers for informed consent were obtained at all institutions. Our inclusion criteria included (a) hospitalized patients who were positive for COVID-19 by means of real-time reverse-transcriptase polymerase chain reaction testing (Sentinel Diagnostics, Milan, Italy) of respiratory secretions obtained by means of bronchoalveolar lavage, endotracheal aspirate, nasopharyngeal swab, or oropharyngeal swab from February 29 to April 4, 2020; (b) presence of acute neurologic symptoms during hospital stay; and (c) any neurologic imaging studies, including brain or spine imaging. We reviewed the electronic medical records to extract clinical, laboratory, and demographic data.Image AcquisitionAll images were obtained as per standard of care protocols. MRI scans of brain and spine were obtained with 1.5-T scanners with standardized protocols. Gadopentetate dimeglumine (0.1 mmol/kg gadobutrol [Gadovist; Bayer, Berlin, Germany]) was used for contrast material–enhanced studies.Image InterpretationThe neurologic imaging characteristics that were evaluated are listed in Table 1. All scans were initially analyzed by the institution's own neuroradiologists. Subsequently, all images were reviewed by three neuroradiologists in consensus (R.G., L.S., and A.C., with 30, 14, and 32 years of neuroradiology experience, respectively).Table 1: Neuroimaging Characteristics of Hospitalized Patients with New Onset of Neurologic Symptoms after COVID-19Statistical AnalysisContinuous variables are presented as means ± standard deviations and were compared between patients with altered mental status by using the Student t test; categoric variables are presented as frequencies with percentages. All statistical analyses were performed by using software (Stata, version 15; StataCorp, College Station, Tex). P < .05 was indicative of a statistically significant difference.ResultsA total of 725 consecutive hospitalized patients with COVID-19 were reviewed. Of these 725 patients, 108 (15%) met the eligibility criteria (Fig 1). Of the 108 patients, 107 (99%) were examined with unenhanced brain CT, 17 (16%) with head and neck CT angiography, and 20 (18%) with brain MRI. Of the 20 patients who underwent brain MRI, 10 (50%) underwent MRI with and without intravenous contrast material, 10 (50%) underwent head and neck MR angiography, and three underwent additional MRI of the whole spine for evaluation of lower extremity weakness. Table 2 summarizes the demographic characteristics, medical history, and neurologic characteristics. The most common neurologic symptoms were altered mental status in 64 of the 108 patients (59%) and ischemic stroke in 34 (31%). Of the 108 patients, 31 (29%) had no known past medical history and 77 (71%) had at least one of the following chronic disorders: coronary artery disease (n = 25, 23%), cerebrovascular disease (n = 15, 14%), hypertension (n = 55, 51%), and diabetes (n = 30, 28%). Of the 31 patients without known past medical history (age range, 16–62 years) (29%), 10 had acute ischemic infarcts and two had intracranial hemorrhage. Seventy-one of the 108 patients (66%) had no acute findings on brain CT scans; seven of the 20 patients who underwent MRI (35%) had acute abnormalities on brain MRI scans. There was a statistically significant association between the prevalence of altered mental status and patient age (mean age, 72 years ± 11 vs 64 years ± 18; P = .007).Figure 1: Study flowchart. COVID-19 = coronavirus disease 2019, CTA = CT angiography, MRA = MR angiography, MS = multiple sclerosis, PRES = posterior reversible encephalopathy syndrome, RT-PCR = real-time reverse-transcriptase polymerase chain reaction.Figure 1:Download as PowerPointFigure 2: Images of acute encephalopathy in a 60-year-old-man without history of seizures who presented with convulsion. A, B, Fluid-attenuated inversion-recovery images show multifocal areas of hyperintensity in the right cerebellum (arrow in A), left anterior cingular cortex, and superior frontal gyrus (arrows in B). C–E, Diffusion-weighted images show restricted diffusion in the left anterior cingulate cortex and superior frontal gyrus (arrows in C), superior frontal and middle temporal gyrus (arrows in D), and right cerebellum (arrows in E), consistent with cerebellar diaschisis. F, MRI scan obtained with gradient-echo sequence shows no hemosiderin deposits.Figure 2:Download as PowerPointTable 2: Characteristics of Hospitalized Patients with COVID-19The main neurologic imaging hallmark was acute ischemic infarcts, which were present in 34 of the 108 patients (31%) (30 [28%] on CT scans and four [20%] on MRI scans). Of these infarcts, 19 (18%) were large (15 in the middle cerebral artery territory, two in the posterior cerebral artery territory, two in the anterior cerebral artery territory), 11 (10%) were small, three (3%) were cardioembolic, and one (1%) had an hypoxic-ischemic encephalopathy pattern. Six of the 108 patients (6%) had intracranial hemorrhages, with subarachnoid hemorrhage being the most common (n = 3, 3%). Additional neurologic imaging findings are shown in Table 1.DiscussionOur study demonstrated that the neurologic imaging features of hospitalized patients with COVID-19 were variable, without a specific pattern but dominated by acute ischemic infarcts and intracranial hemorrhages. We also showed that the neurologic MRI spectrum may include posterior reversible encephalopathy syndrome, hypoxic-ischemic encephalopathy, exacerbation of demyelinating disease, and nonspecific cortical pattern of T2 fluid-attenuated inversion-recovery hyperintense signal with associated restriction diffusion that may be caused by systemic toxemia, viremia, and/or hypoxic effects (9). Currently, we have a poor mechanistic understanding of the neurologic symptoms in patients with COVID-19, whether these are arising from critical illness or from direct central nervous system invasion of severe acute respiratory syndrome coronavirus 2 (10). Accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have a cytokine storm syndrome that could be a trigger for ischemic strokes, probably related to the prothrombotic effect of the inflammatory response (3,11).Our results showed a lower prevalence of central nervous system symptoms than the Wuhan experience (8) (15% vs 25%, respectively); however, the prevalence of ischemic strokes was higher in our study (31% vs 11%). Furthermore, our findings also support the suggested potential for COVID-19–associated Guillain-Barré syndrome and variants (12). None of our patients showed abnormal parenchymal or leptomeningeal enhancement. In conclusion, neurologists and neuroradiologists should be familiar with the broad spectrum of neurologic imaging patterns associated with COVID-19.Disclosures of Conflicts of Interest: A.M. disclosed no relevant relationships. L.S. disclosed no relevant relationships. A.V. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: institution has grants/grants pending rom Cerenovus. Other relationships: disclosed no relevant relationships. M.L. disclosed no relevant relationships. A.R. disclosed no relevant relationships. M.G. disclosed no relevant relationships. S.S. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: is a paid consultant for Novocure; has a grant pending from Sontag. Other relationships: has patents planned, pending, or issued. B.Z. disclosed no relevant relationships. A.C. disclosed no relevant relationships. S.B. disclosed no relevant relationships. P.C. disclosed no relevant relationships. A. Paschè disclosed no relevant relationships. E.P. disclosed no relevant relationships. A. Padovani disclosed no relevant relationships. R.G. disclosed no relevant relationships.AcknowledgmentsWe thank all patients and their families involved in the study.Author ContributionsAuthor contributions: Guarantors of integrity of entire study, A.M., R.G.; study concepts/study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; approval of final version of submitted manuscript, all authors; agrees to ensure any questions related to the work are appropriately resolved, all authors; literature research, A.M., L.S., A.V., A.R., S.S., S.B., P.C., E.P., A. Padovani, R.G.; clinical studies, A.M., M.L., A.C., P.C., A. Paschè, E.P., A. Padovani; experimental studies, A.C., P.C., A. Paschè; statistical analysis, A.M., L.S., B.Z., P.C., R.G.; and manuscript editing, A.M., L.S., A.V., A.R., M.G., S.S., B.Z., S.B., P.C., E.P., A. Padovani, R.G.* A.M. and R.G. contributed equally to this work.References1. Coronavirus disease 2019 (COVID-19) Situation Report – 115. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200514-covid-19-sitrep-115.pdf?sfvrsn=3fce8d3c_6. Published May 14, 2020. Google Scholar2. Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology 2020;295(1):202–207. Link, Google Scholar3. Li Y, Wang M, Zhou Y, et al. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. SSRN Electronic Journal 2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371480/. Published online July 2, 2020. Google Scholar4. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology doi:10.1148/radiol.2020201187. Published online March 31, 2020. Google Scholar5. Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus 2020;12(3):e7352. Google Scholar6. Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 2020;382(23):2268–2270. Crossref, Medline, Google Scholar7. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020;94:55–58. Crossref, Medline, Google Scholar8. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol doi:10.1001/jamaneurol.2020.1127. Published online April 10, 2020. Google Scholar9. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun doi:10.1016/j.bbi.2020.03.031. Published online March 30, 2020. Google Scholar10. Zochodne DW. SARS, SIRS, and neurological disease. Arch Neurol 2004;61(11):1647–1648. Crossref, Medline, Google Scholar11. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395(10229):1033–1034. Crossref, Medline, Google Scholar12. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020;19(5):383–384. Crossref, Medline, Google ScholarArticle HistoryReceived: Apr 30 2020Revision requested: May 6 2020Revision received: May 15 2020Accepted: May 18 2020Published online: May 21 2020Published in print: Nov 2020 FiguresReferencesRelatedDetailsCited ByA Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2DominikaBedran, GeorgesBedran, SachinKote21 February 2024 | Vaccines, Vol. 12, No. 3Topographical Distribution of Neuroanatomical Abnormalities Following COVID-19 InvasionCeydaKiyak, Ogochukwu AnnIjezie, Joseph A.Ackah, MatthewArmstrong, JakeCowen, DenizCetinkaya, HanaBurianová, Theophilus N.Akudjedu11 September 2023 | Clinical Neuroradiology, Vol. 34, No. 1COVID-19 neuroimaging update: pathophysiology, acute findings, and post-acute developmentsAndrew C.McClelland, Steven J.Benitez, JudahBurns2024Mar1 | Seminars in Ultrasound, CT and MRI, Vol. 77Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's diseaseLouiseReveret, ManonLeclerc, VincentEmond, CyntiaTremblay, AndréanneLoiselle, PhilippeBourassa, David A.Bennett, Sébastien S.Hébert, FrédéricCalon2 October 2023 | Acta Neuropathologica Communications, Vol. 11, No. 1Effects of COVID-19 on cognition and brain healthSijiaZhao, SofiaToniolo, AdamHampshire, MasudHusain2023Nov1 | Trends in Cognitive Sciences, Vol. 27, No. 11Neurological complications and effects of COVID-19: Symptoms and conceivable mechanismsElifSarıoğlu, Sezen YılmazSarıaltın, TülayÇoban2023Sep1 | Brain Hemorrhages, Vol. 4, No. 3Neurological Complications in MIS-C: Case ReportEdinBotan, MetinAy, MerveBoyraz, DeryaBako, ServetYüce30 April 2023 | Pediatric Academic Case Reports, Vol. 2, No. 2Stroke Risk Related to Coronavirus Disease-2019PamelaPourciau, Britta C.Smith2023 | Critical Care Nursing Clinics of North America, Vol. 35, No. 1Neurological manifestations associated with SARS-CoV-2 infection: an updated review.DianaCevallos-Macías, GilbertoVizcaíno Salazar, AlineSiteneski2023 | Investigación Clínica, Vol. 64, No. 1COVID-19 and Vasa vasorum: New Atherogenic Factor? A Case Report and Autopsy FindingsJulia A.Macarova, Sofia A.Malakhova, Tatiana A.Novitskaya, Valeria A.Shapkina, Leonid P.Churilov2023 | Diagnostics, Vol. 13, No. 6Neuroimaging findings and neurological manifestations in hospitalized COVID-19 patients: Impact of cancer and ventilatory support statusLilyMcCarthy, OleksandrKhegai, JonathanGoldstein, PuneetBelani, PuneetPawha, ShingoKihira, BrianMathew, KapilGururangan, QingHao, AnuradhaSingh, AllisonNavis, Bradley N.Delman, NathalieJette, PritiBalchandani, YiminChen2023 | PLOS ONE, Vol. 18, No. 3Neurological manifestations of COVID-19: a retrospective observational study based on 1060 patients with a narrative reviewAlbertoNegro, MarioTortora, LauraGemini, Arturode Falco, FrancescoSomma, Vincenzod'Agostino2023 | Acta Radiologica, Vol. 64, No. 5REPRINTED WITH PERMISSION OF EFIC EJP: 27 (2023): 4453: A systematic review and meta-analysis of neuropathicpain associated with coronavirus disease 2019GiuliaDi Stefano, PietroFalco, EleonoraGalosi, GiuseppeDi Pietro, CaterinaLeone, AndreaTruini2023 | BÓL, Vol. 24, No. 1COVID-19-induced headache in Boston and the vicinityBart K.Chwalisz, Vi K.Le, Jennifer R.Cheng, AayusheeJain, M.Brandon Westover, Hsinlin T.Cheng2023 | Journal of Clinical Virology Plus, Vol. 3, No. 2A systematic review and meta‐analysis of neuropathic pain associated with coronavirus disease 2019GiuliaDi Stefano, PietroFalco, EleonoraGalosi, GiuseppeDi Pietro, CaterinaLeone, AndreaTruini2023 | European Journal of Pain, Vol. 27, No. 1The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemicYoussefAit Hamdan, FatimaEl Amerany, JacquesDesbrières, AbdessadekAghrinane, HassaneOudadesse, MohammedRhazi2023 | Polymer Bulletin, Vol. 80, No. 10Imaging Markers of Neurologic Damage in COVID-19: A Systematic ReviewSara TavaresAraújo, Clara TavaresAraújo, RafaelSilva e Castro, Lara Machadode Oliveira Brügger, Nathália GualbertoSouza e Silva, Debora Marquesde Miranda, Ana CristinaSimões e Silva2023 | Current Medicinal Chemistry, Vol. 30, No. 9Brain disorders: Impact of mild SARS-CoV-2 may shrink several parts of the brainPuranam RevanthKumar, B.Shilpa, Rajesh KumarJha2023 | Neuroscience & Biobehavioral Reviews, Vol. 149Neuropsychiatric symptoms in the psychiatric counseling of patients admitted with COVID-19 infectionMohammad Reza ShegarfNakhaei, Ahmad AliNoorbala, Atieh SadeghniiatHaghighi, MohammadArbabi2022Nov1 | Psychiatry Research, Vol. 317SARS-CoV-2 and neurodegenerative diseases: what we know and what we don'tPaulLingor, Antonia F.Demleitner, Andreas W.Wolff, EmilyFeneberg2022 | Journal of Neural Transmission, Vol. 129, No. 9Handbook of Clinical NeurologyFrancescoCavallieri, JohannSellner, MarialuisaZedde, ElenaMoro2022 | , Vol. 189Neuroimaging Findings of Hospitalized Covid-19 Patients: A Canadian Retrospective Observational StudyVibeeshanJegatheeswaran, Michael W. K.Chan, SumonChakrabarti, AdrianFawcett, Yingming AmyChen2022 | Canadian Association of Radiologists Journal, Vol. 73, No. 1A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19)BaharBahranifard, SomayehMehdizadeh, AliHamidi, AlirezaKhosravi, RaminEmami, KamranMirzaei, RezaNemati, FatemehNemati, MajidAssadi, AliGholamrezanezhad2022 | The Neuroradiology Journal, Vol. 35, No. 1Neuroimaging findings in hospitalized patients with COVID-19AhmedAbdelzaher, MohammadAlQatam, LamyaaAlsarraf, Mohamed H.Beheiri, Shehata FaragShehata, Nermeen A.Elsebaie2022 | Egyptian Journal of Radiology and Nuclear Medicine, Vol. 53, No. 1Rehabilitation of severe neurological complications post SARS-CoV-2 infectionAurelianAnghelescu, Ali-OsmanSaglam, Simona IsabelleStoica, GeluOnose2022 | Balneo and PRM Research Journal, No. Vol.13, no.1Neurological imaging findings in hospitalized COVID-19 patients: a retrospective observational study in two Brazilian reference centersAngelo ChelottiDUARTE, Ricardo Hiroshi MurashitaFUJIKI, Larissa Freitas PeixotoGLÓRIA, Diego CardosoFRAGOSO, Felipe TorresPACHECO, CamilaCALVI, MarcosROSA-JÚNIOR, Antonio Carlos MartinsMAIA JUNIOR, Antônio José daROCHA2022 | Arquivos de Neuro-Psiquiatria, Vol. 80, No. 5COVID-19-associated encephalitis or Creutzfeldt–Jakob disease: a case reportGooyaTayyebi, Seyed KazemMalakouti, BehnamShariati, LeilaKamalzadeh2022 | Neurodegenerative Disease Management, Vol. 12, No. 1Neuroimaging Findings of SARS-CoV-2 InfectionA.Aein, S.Khanpara, R.Samant, Y.F.Cai, L.Nunez, S.I.Savitz, J.M.Romero, R.F.Riascos2022 | Neurographics, Vol. 12, No. 3Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative ReviewYanHuang, QiongLing, AnneManyande, DuozhiWu, BoqiXiang2022 | Frontiers in Neuroscience, Vol. 16Putative Role of the Lung–Brain Axis in the Pathogenesis of COVID-19-Associated Respiratory Failure: A Systematic ReviewFrancescoGentile, TommasoBocci, SilviaCoppola, TommasoPozzi, LeoModafferi, AlbertoPriori, DavideChiumello2022 | Biomedicines, Vol. 10, No. 3Ischemic and Hemorrhagic Cerebrovascular Events Related to COVID-19 Coagulopathy and HypoxemiaMichałSojka, AnnaDrelich-Zbroja, MarylaKuczyńska, MateuszCheda, IzabelaDąbrowska, EwaKopyto, IzabelaHalczuk, MonikaZbroja, WeronikaCyranka, TomaszJargiełło2022 | International Journal of Environmental Research and Public Health, Vol. 19, No. 18Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19Marina Y.Khodanovich, Daria A.Kamaeva, Anna V.Naumova2022 | International Journal of Molecular Sciences, Vol. 23, No. 19Perioperative Complications of Patients with SARS-CoV-2 Infection in NeurosurgeryLadinaGreuter, ChristianZweifel, RaphaelGuzman, JehudaSoleman2022 | Journal of Clinical Medicine, Vol. 11, No. 3The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case SeriesTeresaGrieco, VitoGomes, AlfredoRossi, CarmenCantisani, Maria ElisabettaGreco, GiovanniRossi, AlviseSernicola, GiovanniPellacani2022 | Journal of Clinical Medicine, Vol. 11, No. 15Neuro–Immune Interactions in Severe COVID-19 InfectionElenaRossi, LucianoMutti, AndreaMorrione, AntonioGiordano2022 | Pathogens, Vol. 11, No. 11Manifestaciones neurológicas en pacientes hospitalizados con SARS-CoV-2: una cohorte mexicanaPaul DavidUribe-Jaimes, PaolaGuraieb-Chahin, Nadia AlejandraGandarilla-Martínez, Raúl AnwárGarcía-Santos, IreneTreviño-Frenk, Manuel AlejandroDel Río-Quiñones, MicheleBreda-Yepes, Francisco ManuelMartínez-Carrillo, José EduardoSan Esteban-Sosa2022 | Anales Médicos de la Asociación Médica del Centro Médico ABC, Vol. 67, No. 4COVID-19-Induced Seizures: A Meta-Analysis of Case Series and Retrospective CohortsHelaiHussaini, SylvetteRogers, SaurabhKataria, KhalidUddin, Khalid HMohamed, Alaa SMohamed, FarhanTariq, SarfarazAhmad, AnumAwais, ZahoorAhmed, AnthonyChukwurah, AadilKhan2022 | CureusCytokine Storm and Neuropathological Alterations in Patients with Neurological Manifestations of COVID-19ChristosTsagkaris, MuhammadBilal, IremAktar, YoussefAboufandi, AhmetTas, Abdullahi TundeAborode, Tarun KumarSuvvari, ShoaibAhmad, AnastasiiaShkodina, RachanaPhadke, Marwa S.Emhamed, Atif AminBaig, AthanasiosAlexiou, Ghulam Md.Ashraf, Mohammad AmjadKamal2022 | Current Alzheimer Research, Vol. 19, No. 9Incidence of white matter lesions in hospitalized COVID‐19 patients: A meta‐analysisAarushiRastogi, Sonu Menachem MaimonidesBhaskar2022 | Microcirculation, Vol. 29, No. 3Neuroimaging of Covid-19. First Insights based on Clinical CasesOrnellaManara, GiulioPezzetti, SimonettaGerevini2021A comprehensive review of imaging findings in COVID-19 - status in early 2021AliAfshar-Oromieh, HelmutProsch, CorneliaSchaefer-Prokop, Karl PeterBohn, IanAlberts, ClemensMingels, MajdaThurnher, PaulCumming, KuangyuShi, AlanPeters, SilvanaGeleff, XiaoliLan, FengWang, AdrianHuber, ChristophGräni, Johannes T.Heverhagen, AxelRominger, MatthiasFontanellaz, HeikoSchöder, AndreasChriste, StavroulaMougiakakou, LukasEbner2021 | European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, No. 8The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C)Sophie I.Mavrogeni, GenovefaKolovou, VasileiosTsirimpis, DimitriosKafetzis, GeorgiosTsolas, LamprosFotis2021 | Rheumatology International, Vol. 41, No. 6Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literatureDavide TizianoDi Carlo, NicolaMontemurro, GiandomenicoPetrella, GabrieleSiciliano, RobertoCeravolo, PaoloPerrini2021 | Journal of Neurology, Vol. 268, No. 5Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literatureFedericoCagnazzo, CarolineArquizan, ImadDerraz, CyrilDargazanli, Pierre-HenriLefevre, CarlosRiquelme, NicolasGaillard, IsabelleMourand, GregoryGascou, AlainBonafe, VincentCostalat2021 | Journal of Neurology, Vol. 268, No. 8Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case seriesRaphael L.Tuma, Bruno F.Guedes, RafaelCarra, BrunoIepsen, JúliaRodrigues, Antonio EdvanCamelo-Filho, GabrielKubota, MaíraFerrari, AdalbertoStudart-Neto, Mariana HiromiOku, SaraTerrim, Cesar C. B.Lopes, Carlos E. B.Passos Neto, Matheus D.Fiorentino, Julia C. C.Souza, José Pedro S.Baima, TomásSilva, IagoPerissinotti, Maria da Graça M.Martin, MarciaGonçalves, IdaFortini, JerusaSmid, TarsoAdoni, LeandroLucato, RicardoNitrini, HélioGomes, Luiz H.Castro2021 | Neurological Sciences, Vol. 42, No. 2Demyelination as a result of an immune response in patients with COVID-19ZahraShabani2021 | Acta Neurologica Belgica, Vol. 121, No. 4Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative studyCamilla ELindan, KshitijMankad, DipakRam, Larry KKociolek, V MichelleSilvera, NathalieBoddaert, Stavros MichaelStivaros, SusanPalasis, SameenAkhtar, DouglasAlden, SurajAmonkar, PascaleAouad, MélodieAubart, Jose AlejandroBacalla, Alci
Referência(s)